These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 1370774

  • 1. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K.
    Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
    Misko IS, Schmidt C, Moss DJ, Burrows SR, Sculley TB.
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():405-9. PubMed ID: 1704413
    [Abstract] [Full Text] [Related]

  • 3. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
    Misko IS, Sculley TB, Schmidt C, Moss DJ, Soszynski T, Burman K.
    Cell Immunol; 1991 Feb 01; 132(2):295-307. PubMed ID: 1846323
    [Abstract] [Full Text] [Related]

  • 8. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 01; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 9. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S, Cuomo L, Klein E, Masucci MG.
    Cell Immunol; 1991 Oct 15; 137(2):501-13. PubMed ID: 1654213
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies.
    Misko IS, Pope JH, Hütter R, Soszynski TD, Kane RG.
    Int J Cancer; 1984 Feb 15; 33(2):239-43. PubMed ID: 6319303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 15; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 16. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T, Hirano T, Sakaguchi N, Teranishi T, Tsuyuguchi I, Nagao N, Naito N, Yoshimura K, Okubo Y, Tohda H, Oikawa A.
    J Immunol; 1981 May 15; 126(5):1697-701. PubMed ID: 6163815
    [Abstract] [Full Text] [Related]

  • 17. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ.
    J Exp Med; 1996 Mar 01; 183(3):1215-28. PubMed ID: 8642263
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D, Herzog WR, Heeg K, Wagner H, Reimann J.
    J Mol Cell Immunol; 1987 Mar 01; 3(1):49-60. PubMed ID: 2855406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.